Frost & Sullivan Award to Ebit (Esaote Group) for Suitestensa Technically Advanced Cardiovascular Information System Integration Platform – CVIS PACS - European Medical Journal

Frost & Sullivan Award to Ebit (Esaote Group) for Suitestensa Technically Advanced Cardiovascular Information System Integration Platform – CVIS PACS

2 Mins

Genoa, 18 November 2015 –   Frost & Sullivan, a global organization collaborating with international companies to leverage innovation and growth opportunities, presented the “2015 European Award for Technology Leadership” to Ebit, the Esaote’s Healthcare IT Company focused on developing and selling RIS CVIS PACS software for integrated workflows in hospital enterprise processes. The Frost & Sullivan Award recognizes Ebit for Suitestensa CVIS PACS, an advanced Cardiovascular Information System Integration Platform.

Based on a Frost & Sullivan recent analysis of the cardiovascular information system (CVIS) market, Suitenstensa was acknowledged as a highly innovative and comprehensive IT system.  Suitestensa CVIS-PACS is the most complete software suite, encompassing all cardiology specialities and allowing diagnostic image acquisition, archiving, distribution and management within healthcare networks.   Its peculiar strength, enabling doctors to access and track both current and previous patient reports, images, and test results, is extremely helpful to develop a thorough and valid diagnostic plan, while reducing times and costs involved.

Born first within the cardiovascular department, Suitestensa is now an “enterprise –wide” IT system, that shares data and information between hospital departments and even hospitals, also thanks to its aligned archiving server systems. Featuring an effective equipment vendor-agnostic profile, Suitestensa has a broad compatibility and interoperability of all software, technologies, and modalities involved, so that it has a multi-departmental approach managing diagnostics from Cardiac Catheterization, Electrophysiology, Echocardiography, Electrocardiography, General Cardiology, Cardiovascular Surgery, Interventional Cardiology and Endovascular Surgery.

“Ebit’s primary commercialisation focus has been its home market of Italy, where it currently holds more than 50 percent of the market share,” noted Frost & Sullivan Research Analyst Siddharth Saha. “Even when Suitestensa expanded into different markets such as Brazil, Colombia, Argentina, China, Germany and parts of Eastern Europe, Ebit continued to offer full technological support for the platform by building and maintaining support facilities in those countries or regions.”

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products but also enables the development of newer products and applications.

Krishna Srinivasan, Global President and Managing Partner, Frost & Sullivan, sums up “Technology-rich companies with strong commercialisation strategies benefit from the increased demand for high-quality, technologically innovative products. We are pleased to recognise Ebit for its abiding investment and continuous focus in leveraging technology to drive customer value and business impact.”

Great satisfaction in Ebit and Esaote team for this new award, recognizing the commitment of the Group to deliver innovation and to meet the continuously changing demands of the healthcare community.

About Esaote. With €262.3 million consolidated sales in 2014 (of which 65% were generated from international markets), Esaote Group is a leading player in the biomedical equipment sector, with a focus on ultrasound, dedicated magnetic resonance and software for managing the diagnostic process. Esaote has about 1,250 employees, 50% of whom are based outside of Italy. Esaote has manufacturing and research units in Italy, the Netherlands and China. Esaote is internationally recognised as one of the “ Top Ten” diagnostic imaging companies in the world and enjoys the co-operation of worldwide scientific and clinical research centres and universities.

Ebit is one of the three IT Companies of the Esaote Group and it is focused on the development and sale of RIS CVIS PACS software for workflow management in Cardiology departments but also in Nuclear Medicine, Radiotherapy, Breast Imaging, Orthopaedics. Ebit’s mission is to deliver healthcare professionals with streamlined filmless and paperless workflows, advanced clinical applications and effective integration of all software and  modalities, with   the aim of improving organization, reducing hospitalization and costs, increasing diagnostic accuracy and optimizing services via the web and mobile devices.

Information about the Esaote Group and its products is available at www.esaote.comCommunications & External Relations: Mariangela Dellepiane

Tel.: +39-010-6547238
Mob.: +39-335-1289783
e-mail: [email protected]




The materials in this electronic mail transmission(including all attachments) are private and confidentialand are the property of Esaote S.p.A. Unauthorized disclosure, copying, distribution,or the taking of any action in reliance on the contentsof this material is strictly prohibited.Please notify the sender if you have received this in error.

Le informazioni contenute in questo messaggio diposta elettronica e relativi allegati sono proprieta’ di Esaote S.p.A. e sono riservate;ne e’ vietata la diffusione in qualunque modo eseguita.Qualora Lei non fosse la persona a cui il presentemessaggio e’ destinato, La invitiamo ad eliminarlo e ad informare colui che lo ha inviato.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?